|
1
|
Zhou XD, Wang XY, Qu FJ, et al: Detection
of cancer stem cells from the C6 glioma cell line. J Int Med Res.
37:503–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qiu B, Zhang D, Tao J, Wu A and Wang Y: A
simplified and modified procedure to culture brain glioma stem
cells from clinical specimens. Oncol Lett. 3:50–54. 2012.PubMed/NCBI
|
|
3
|
Hwang-Verslues WW, Kuo WH, Chang PH, et
al: Multiple lineages of human breast cancer stem/progenitor cells
identified by profiling with stem cell markers. PLoS ONE.
4:e83772009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
6
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang DG, Jiang AG, Lu HY, Zhang DG, Zhang
LX and Gao XY: Isolation, cultivation and identification of human
lung adenocarcinoma stem cells. Oncol Lett. 9:47–54. 2015.
|
|
8
|
Varnat F, Duquet A, Malerba M, et al:
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI
signalling that is essential for tumour growth,
recurrence,metastasis and stem cell survival and expansion. EMBO
Mol Med. 1:338–351. 2009. View Article : Google Scholar
|
|
9
|
Sullivan JP, Minna JD and Shay JW:
Evidence for self-renewing lung cancer stem cells and their
implications in tumour initiation, progression and targeted
therapy. Cancer Metastasis Rev. 29:61–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng M, Zhao XH, Ning Q, Hou L, Xin GH and
Liu LF: Tumor stem cells: A new approach for tumor therapy
(Review). Oncol Lett. 4:187–193. 2012.PubMed/NCBI
|
|
11
|
Xu Y, Hu YD, Zhou J, Zhang MH, Yuan WW and
Luo Y: shRNA targeting Bmi1 impedes the self-renewal of
cisplatin-enriched stem-like cells in human A549 cells. Oncol Rep.
28:629–639. 2012.PubMed/NCBI
|
|
12
|
Cantrell DA: Phosphoinositide 3-kinase
signaling pathways. J Cell Sci. 114:1439–1445. 2001.PubMed/NCBI
|
|
13
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun XY, Ding LS, Jin XD, et al:
Correlation of PI3K/Akt/mTOR signal transduction pathway with both
malignancy progression and prognosis of human gliomas. Chin J
Neuromed. 10:24–28. 2011.In Chinese.
|
|
15
|
Missiaglia E, Dalai I, Barbi S, et al:
Pancreatic endocrine tumors:expression profiling evidences a role
for AKT-mTOR pathway. J Clin Oncol. 28:245–255. 2010. View Article : Google Scholar
|
|
16
|
Jiang AG, Yu H and Huang JA: Expression
and clinical significance of the PI3K/Akt signal transduction
pathway in non-small cell lung carcinoma. Oncol Lett. 8:601–607.
2014.PubMed/NCBI
|
|
17
|
Sunayama J, Sato A, Matsuda K, et al: Dual
blocking of mTor and PI3K elicits a prodifferentiation effect on
glioblastoma stem-like cells. Neuro Oncol. 12:1205–1219.
2010.PubMed/NCBI
|
|
18
|
Zhou J, Wulfkuhle J, Zhang H, et al:
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer
stem-like cells is required for viability and maintenance. Proc
Natl Acad Sci USA. 104:16158–16163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Y, Iwanaga K, Raso MG, et al:
Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell
expansion in mouse models of oncogenic k-ras-induced lung cancer.
PLoS One. 3:e22202008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Loebinger MR, Eddaoudi A, Davies D and
Janes SM: Mesenchymal stem cell delivery of TRAIL can eliminate
metastatic cancer. Cancer Res. 69:4134–4142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Levi E, Misra S, Du J, Patel BB and
Majumdar AP: Combination of aging and dimethylhydrazine treatment
causes an increase in cancer-stem cell population of rat colonic
crypts. Biochem Biophys Res Commun. 385:430–433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghotra VP, Puigvert JC and Danen EH: The
cancer stem cell microenvironment and anti-cancer therapy. Int J
Radiat Biol. 85:955–962. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sung JM, Cho HJ, Yi H, et al:
Characterization of s stem cell population in lung cancer A549
cells. Biochem Biophys Res Commun. 371:163–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Levina V, Marrangoni AM, DeMarco R,
Gorelik E and Lokshin AE: Drug-selected human lung cancer stem
cells: cytokine network, tumorigenic and metastatic properties.
PLoS One. 3:e30772008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ota S, Ishii G, Goto K, et al:
Immunohistochemical expression of BCRP1 and ERCC1 in biopsy
specimen predicts survival in advanced non-small-cell lung cancer
treated with cisplatin-based chemotherapy. Lung Cancer. 64:98–104.
2009. View Article : Google Scholar
|
|
27
|
Smith KS, Chanda SK, Lingbeek M, et al:
Bmi-1 regulation of INK4A-ARF is adownstream requirement for
transformation of hematopoietic progenitors by E2a-Pbx1. Mol Cell.
12:393–400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gong C, Guo FJ, Qin L, et al: LY294002
inhibits proliferation of cancer stem-like cells from human
osteosarcoma via down-regulation of PI3K/AKT signaling pathwa. Chin
J Exp Surg. 28:2215–2217. 2011.In Chinese.
|
|
30
|
Sunayama J, Sato A, Matsuda K, et al: Dual
blocking of mTor and PI3K elicits a prodifferentiation effect on
glioblastoma stem-like cells. Neuro Oncol. 12:1205–1219.
2010.PubMed/NCBI
|
|
31
|
Cayrol C, Knibiehler M and Ducommun B: p21
binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient
cells. Oncogene. 16:311–320. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lebeau A, Unholzer A, Amann G, et al:
EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell
proliferation and steroid hormone receptor status in ductal
carcinoma in situ of the breast. Breast Cancer Res Treat.
79:187–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
